Serum Institute to produce additional 100 million COVID-19 vaccine doses
Serum Institute of India (SII) has announced today on September 29, 2020 that it will produce an additional 100 million COVID-19 vaccine doses for India and other low and middle-income countries in 2021. The announcement is taking forward the collaboration that was made between the Serum Institute of India, GAVI Vaccine Alliance and the Bill & Melinda Gates Foundation.
- Earlier, in August the institute had announced to deliver 100 million doses to India and other low and middle-income countries.
- With the latest announcement, a total of 200 million doses of COVID-19 vaccines will now be delivered to India by 2021.
- The Serum Institute of India in a press release said with the support of Gavi and the Bill & Melinda Gates Foundation the manufacturing would be accelerated further.
- The COVID-19 vaccines will cost a maximum of USD 3 per dose.
- Bill & Melinda Gates Foundation will be funding a further USD 150 million to Gavi under the Strategic Investment Fund. The total funding provided through this collaboration stands at USD 300 million.
Recent updates by Ministry
- The Union Ministry of Health and Family Welfare assured that first COVID-19 vaccine will likely be available in India by early 2021.
- The Health Ministry recently launched a special web portal developed by Indian Council of Medical Research (ICMR) in order to provide all the important information regarding coronavirus and vaccine development. A National Clinical Registry of COVID-19 has been created by ICMR to collect all data regarding the treatments, clinical and laboratory investigations and the outcomes of hospitalized COVID-19 patients in India.